Samsung Biologics Co.,Ltd.
207940
Rank in Stocks
#496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Share Price
$1,028.49
Market Cap
$47.88B
Change (1 day)
-3.67%
Change (1 year)
-18.37%
Country
KR
Trade Samsung Biologics Co.,Ltd. (207940)
Category
Healthcare
Stock split history for Samsung Biologics Co.,Ltd. (207940)
Samsung Biologics Co.,Ltd. stock (symbol: 207940) underwent a total of 1 stock splits.
The most recent stock split occurred on Oct 30, 2025.
One 207940 share bought prior to Oct 30, 2025 would equal to 0.650391 207940 shares today.
The most recent stock split occurred on Oct 30, 2025.
One 207940 share bought prior to Oct 30, 2025 would equal to 0.650391 207940 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2025-10-30 | 650391:1000000 | x0.650391 | x0.650391 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
